CircRNA-UCK2 Increased TET1 Inhibits Proliferation and Invasion of Prostate Cancer Cells Via Sponge MiRNA-767-5p

A majority of the patients with advanced prostate cancer initially respond to androgen deprivation therapy and enzalutamide therapy, but eventually enter the castration-resistant prostate cancer (CRPC) phase. Some studies have shown that the activation of other signalling pathways in CRPC cells repl...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Zhendong, Xu, Chengdang, Wu, Gang, Liu, Bo, Wu, Denglong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884924/
https://www.ncbi.nlm.nih.gov/pubmed/31844675
http://dx.doi.org/10.1515/med-2019-0097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884924/
https://www.ncbi.nlm.nih.gov/pubmed/31844675
http://dx.doi.org/10.1515/med-2019-0097

Ejemplares similares